3-Hydroxy-4-(methoxycarbonyl)phenylboronic acid, 98%, 25g

trans-ethyl (1R,2R)-2-cyanocyclopropane-1-carboxylate, 95.0%, 5g

5-Formyl-1-methyl-1h-pyrrole-2-carboxylic acid, 98%, 250mg

(S)-2,2'-bis(Diphenylphosphino)-1,1'-binaphthyl monooxide, 95%, 10mg

(E)-Ethyl 3-(4-(benzyloxy)-3-methoxyphenyl)acrylate, 95.0%, 5g

2-(2,3-Difluorophenyl)ethanol, 95.0%, 1g

Solution de gélatine ROTI®Cell

Objectif Plan PLi 10x/0.25 IOS corrigé à l'infini

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 5g

2,5-Dioxopyrrolidin-1-yl 2,2,2-trifluoroacetate, 97%, 5g

1,2,3,4,4A,5-Hexahydrobenzo[b]pyrazino[1,2-d][1,4]diazepin-6(7H)-one dihydrochloride, 97.0%, 250mg

1,3-Dibromo-5-fluoro-2-methylbenzene, 98%, 10g

3-BROMO-7-CHLORO-1,5-NAPHTHYRIDINE, 95.0%, 1g